Hope Resverlogix gains some new insights from it.
|
4
|
Resverlogix Corp.
|
Aug 03, 2021 08:29PM
|
Holy Grail treatment for COVID-19 remains out of reach. But options exist
|
4
|
Resverlogix Corp.
|
Dec 26, 2020 02:34AM
|
Hmmm, tell me you don't find the timing interesting.
|
3
|
Resverlogix Corp.
|
Nov 09, 2021 09:49PM
|
Hey, wait a minute...hope nobody is blindfolded here.
|
5
|
Resverlogix Corp.
|
May 12, 2021 06:08PM
|
Hepalink or Ori?
|
4
|
Resverlogix Corp.
|
Oct 06, 2020 01:45PM
|
Haven't written off a potential role for Apabetalone to play yet.
|
7
|
Resverlogix Corp.
|
Apr 01, 2020 07:18PM
|
Good news, bad news!
|
6
|
Resverlogix Corp.
|
May 05, 2022 02:08PM
|
Good luck!
|
4
|
Resverlogix Corp.
|
Sep 18, 2021 05:53PM
|
Gene changes might explain long-haul COVID-19 symptoms .
|
7
|
Resverlogix Corp.
|
Apr 28, 2021 11:58PM
|
From early March 2021.
|
6
|
Resverlogix Corp.
|
May 20, 2021 10:57PM
|
From 2018.
|
4
|
Resverlogix Corp.
|
May 02, 2020 11:30PM
|
For those following EXO-CD24.
|
5
|
Resverlogix Corp.
|
May 28, 2021 10:03PM
|
Firms Line Up to IPO in Hong Kong After Asia’s Biggest Week for Listings.
|
2
|
Resverlogix Corp.
|
Jun 16, 2020 02:54AM
|
FDA busts Merck's Keytruda in triple-negative breast cancer with a CRL — not unexpected given its disastrous adcomm
|
6
|
Zenith Epigenetics
|
Mar 29, 2021 09:32PM
|
EXO-CD24: Update on the competition.
|
4
|
Resverlogix Corp.
|
Aug 06, 2021 01:26AM
|
EVERSANA™ expands global commercialization solutions with acquisition of Accelera Canada and its partner companies .
|
2
|
Resverlogix Corp.
|
Jul 27, 2021 03:28PM
|
EVERSANA: Partnering & Licensing.
|
3
|
Resverlogix Corp.
|
Jul 15, 2021 12:18PM
|
EVERSANA: Over 5,000 team members globally now.
|
5
|
Resverlogix Corp.
|
Feb 24, 2022 04:02PM
|
Eversana.
|
1
|
Resverlogix Corp.
|
Jun 03, 2021 03:03PM
|
Empowerment for the whining peasants, aka RVX retail...but only if you want it!
|
8
|
Resverlogix Corp.
|
May 28, 2022 03:18PM
|